Astellas Pharma's total assets for Q1 2026 were ¥3.34T, a decrease of -0.11% from the previous quarter. JP:4503 total liabilities were ¥1.85T for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.